Melius MicroBiomics (MMB) integrates microbiology and bioengineering to create innovative live biotherapeutics that promote a healthy microbiome and improve gut health.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 1050-1040 W Georgia St, Vancouver,british Columbia V6e 4h1,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.mmblivebio.com/
- Keywords
- Microbiome, Bioengineering, Biotechnology, Medicine, Gastroenterology, Drug Development, Microbial Therapeutics, Research, Clinical Trials, IBD, Microbiology.
- HQ
- Vancouver, British Columbia
Melius Microbiomics Questions
Melius Microbiomics's website is https://www.mmblivebio.com/
Melius Microbiomics's LinkedIn profile is https://ca.linkedin.com/company/mmblivebio
Melius Microbiomics has
13 employees.
View email and phone details for 13
employees at Melius Microbiomics.
Melius Microbiomics's industry is
Biotechnology Research
Melius Microbiomics's top competitors are
Sinedore Medicine 正弦生醫,
Lunar Therapeutics,
Sustainable Bioproduct Innovations,
Innovate Phytotechnologies,
Insu Therapeutics,
Innovate Phytoceuticals Inc,
Cerecura Nanotherapeutics,
Aspect Biosystems,
Amphoraxe Life Sciences Inc.,
Arrowsmith Genetics.
Melius Microbiomics's categories are Biotechnology Research
Melius Microbiomics's founding year is 2023
